trypan blue has been researched along with Angiogenesis, Pathologic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydemir, EA; Fışkın, K; İmir, N; Koçak, O; Kuruoğlu, A; Şimşek, E | 1 |
| Chalam, KV; Rusovici, R; Sakhalkar, M | 1 |
| Donato, NJ; Johnson, FM; Saigal, B; Talpaz, M | 1 |
3 other study(ies) available for trypan blue and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Dimethyl sulfoxide-caused changes in pro- and anti-angiogenic factor levels could contribute to an anti-angiogenic response in HeLa cells.
Topics: Cell Proliferation; Cell Survival; Dimethyl Sulfoxide; HeLa Cells; Humans; Interferon-gamma; Neovascularization, Pathologic; Substance P; Trypan Blue; Vascular Endothelial Growth Factor A | 2015 |
Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells.
Topics: Angiogenesis Inhibitors; Animals; Annexin A5; Anterior Chamber; Antibodies, Monoclonal, Humanized; Bevacizumab; Cattle; Cell Proliferation; Cell Survival; Cells, Cultured; Cornea; Dose-Response Relationship, Drug; Endothelial Cells; Glaucoma, Neovascular; Humans; Microscopy; Neovascularization, Pathologic; Trypan Blue; Vascular Endothelial Growth Factor A | 2011 |
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Crk-Associated Substrate Protein; Dasatinib; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Focal Adhesion Protein-Tyrosine Kinases; G1 Phase; Gentian Violet; Head and Neck Neoplasms; Humans; Immunoprecipitation; Inhibitory Concentration 50; Laminin; Lung Neoplasms; Neoplasm Invasiveness; Neovascularization, Pathologic; Paxillin; Phosphorylation; Protein-Tyrosine Kinases; Proteoglycans; Pyrimidines; Retinoblastoma Protein; S Phase; Signal Transduction; src-Family Kinases; Thiazoles; Time Factors; Trypan Blue | 2005 |